English | Español

Cancer Support Community
+ Regulatory
Nicholas Gueguen | Jul 19, 2017

Limited insurance plans limit cancer care options, study says
+ Community
John Breslin | Dec 5, 2016

Majority of cancer patients fail to discuss cost with physician, despite increases

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes